United States Biotechnology & Medical Research

Cara Therapeutics Inc (CARA)

Track

Track

Cara Therapeutics Inc. executives have consistently executed planned sales of company stock. The most recent insider trading activity occurred on February 28, 2025, involving President Christopher Posner and General Counsel Scott Terrillion. These divestments follow a recurring pattern of scheduled equity liquidations by key leadership members over the past several quarters.
Ticker: CARA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cara Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
197.70
Quantity 59,770 +31.7%
Value US$238,006
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
260.90
Quantity 58,638 -10.8%
Value US$4,598,566
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
115.74
Quantity 16,664 +4.0%
Value US$4,735,688
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.29
Quantity 3,668 -2.1%
Value US$1,064
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.35
Quantity 4,149 -2.3%
Value US$1,452
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.75
Quantity 3,936 -2.2%
Value US$2,952
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
0.83
Quantity 2,753 -3.0%
Value US$2,285
0.6
Goncalves Joana CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
0.83
Quantity 2,753 -4.9%
Value US$2,285
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.89
Quantity 5,834 -3.1%
Value US$5,192
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
0.89
Quantity 3,293 -3.5%
Value US$2,931
0.6
Goncalves Joana CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
0.89
Quantity 3,293 -5.5%
Value US$2,931
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.53
Quantity 35,575 -16.0%
Value US$18,855
1.3
Posner Christopher PRESIDENT AND CEO Executive Director
Transaction date
Planned sale
Price
0.55
Quantity 4,981 -2.2%
Value US$2,740
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
1.22
Quantity 3,796 -2.3%
Value US$4,631
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
3.07
Quantity 4,307 -2.5%
Value US$13,222
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
3.51
Quantity 2,993 -1.9%
Value US$10,505
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
3.51
Quantity 2,723 -4.8%
Value US$9,558
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
3.51
Quantity 2,483 -2.7%
Value US$8,715
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
4.40
Quantity 3,869 -2.2%
Value US$17,024
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
4.91
Quantity 2,481 -2.7%
Value US$12,182
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
4.91
Quantity 2,733 -1.7%
Value US$13,419
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.91
Quantity 2,481 -4.2%
Value US$12,182
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
9.71
Quantity 6,256 -6.3%
Value US$60,746
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
9.71
Quantity 5,987 -3.3%
Value US$58,134
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
9.71
Quantity 6,802 -4.1%
Value US$66,047
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
9.71
Quantity 6,221 -9.6%
Value US$60,406
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.20
Quantity 2,265 -3.4%
Value US$23,103
3.3
Maynard Ryan D CHIEF FINANCIAL OFFICER Officer
Transaction date
Planned sale
Price
0.53
Quantity 5,488 -40.7%
Value US$2,909
0.6
Goncalves Joana CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
0.53
Quantity 7,770 -11.6%
Value US$4,118
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. Officer
Transaction date
Planned sale
Price
0.53
Quantity 7,770 -7.6%
Value US$4,118
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
11.80
Quantity 4,191 -2.2%
Value US$49,454
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.81
Quantity 2,265 -3.3%
Value US$24,485
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.18
Quantity 2,265 -3.2%
Value US$23,058
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
11.27
Quantity 3,506 -2.1%
Value US$39,513
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
11.27
Quantity 2,561 -2.5%
Value US$28,862
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.27
Quantity 2,992 -4.0%
Value US$33,720
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
11.13
Quantity 14,470 -7.2%
Value US$161,051
2.0
VOGELBAUM MARTIN Non-Executive Director
Transaction date
Sale
Price
10.28
Quantity 10,800 -19.4%
Value US$111,024
BAINS HARRISON M JR Non-Executive Director
Transaction date
Planned sale
Price
9.05
Quantity 7,200 -22.3%
Value US$65,160
3.3
Ives Jeffrey L. Non-Executive Director
Transaction date
Planned sale
Price
9.05
Quantity 3,600 -18.9%
Value US$32,580
1.3
Posner Christopher President and CEO Executive Director
Transaction date
Planned sale
Price
12.67
Quantity 2,006 -1.0%
Value US$25,416
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
11.91
Quantity 1,784 -1.0%
Value US$21,247
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
11.91
Quantity 1,642 -1.6%
Value US$19,556
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
11.91
Quantity 1,642 -2.1%
Value US$19,556
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
11.38
Quantity 1,787 -1.7%
Value US$20,336
Reilly Thomas Charles Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.38
Quantity 2,044 -5.1%
Value US$23,261
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
10.29
Quantity 1,972 -1.9%
Value US$20,292
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
10.29
Quantity 2,114 -1.2%
Value US$21,753
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
10.29
Quantity 1,972 -2.5%
Value US$20,292
3.3
Ives Jeffrey L. Non-Executive Director
Transaction date
Sale
Price
16.04
Quantity 8,180 -53.2%
Value US$131,207
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.15
Quantity 1,000 -2.1%
Value US$17,150
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 1,000 -2.1%
Value US$15,000
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
14.20
Quantity 1,759 -2.4%
Value US$24,978
1.3
Posner Christopher Non-Executive Director
Transaction date
Planned sale
Price
13.04
Quantity 2,304 -12.5%
Value US$30,044
2.0
VOGELBAUM MARTIN Non-Executive Director
Transaction date
Planned sale
Price
13.05
Quantity 8,640 -30.0%
Value US$112,752
3.3
Ives Jeffrey L. Non-Executive Director
Transaction date
Planned sale
Price
13.05
Quantity 2,520 -14.1%
Value US$32,886
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.65
Quantity 3,000 -8.9%
Value US$58,950
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
17.98
Quantity 3,103 -0.3%
Value US$55,792
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.98
Quantity 3,093 -8.4%
Value US$55,612
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
17.98
Quantity 3,358 -2.7%
Value US$60,377
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
17.98
Quantity 3,090 -5.7%
Value US$55,558
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
19.33
Quantity 5,003 -4.3%
Value US$96,708
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
19.33
Quantity 4,004 -8.3%
Value US$77,397
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
19.33
Quantity 11,729 -1.2%
Value US$226,722
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.33
Quantity 3,372 -11.2%
Value US$65,181
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
19.73
Quantity 2,000 -7.1%
Value US$39,460
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.12
Quantity 2,000 -6.7%
Value US$40,240
Terrillion Scott Sec'y; Chief Compliance & G.C. Officer
Transaction date
Planned sale
Price
15.30
Quantity 1,946 -4.4%
Value US$29,774
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
15.30
Quantity 6,078 -0.6%
Value US$92,993
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Officer
Transaction date
Planned sale
Price
15.30
Quantity 2,812 -2.5%
Value US$43,024
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.30
Quantity 1,298 -4.1%
Value US$19,859
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Planned sale
Price
16.00
Quantity 5,000 -0.5%
Value US$80,000
0.6
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 2,000 -6.8%
Value US$30,000
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Sale
Price
14.95
Quantity 5,000 -0.5%
Value US$74,750
0.9
CHALMERS DEREK T President & CEO Executive Director
Transaction date
Sale
Price
15.29
Quantity 7,500 -0.8%
Value US$114,675
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-02-28 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
59,770 +31.7%
197.70
US$238,006 		59,770 +31.7% 197.70 US$238,006
2025-03-04 2025-02-28 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
58,638 -10.8%
260.90
US$4,598,566 		58,638 -10.8% 260.90 US$4,598,566
2025-02-06 2025-02-04 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
16,664 +4.0%
115.74
US$4,735,688 		16,664 +4.0% 115.74 US$4,735,688
2024-11-06 2024-11-04 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
3,668 -2.1%
0.29
US$1,064 		3,668 -2.1% 0.29 US$1,064
2024-08-02 2024-08-01 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
4,149 -2.3%
0.35
US$1,452 		4,149 -2.3% 0.35 US$1,452
2024-05-06 2024-05-02 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
3,936 -2.2%
0.75
US$2,952 		3,936 -2.2% 0.75 US$2,952
2024-04-09 2024-04-05 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
2,753 -3.0%
0.83
US$2,285 		2,753 -3.0% 0.83 US$2,285
2024-04-09 2024-04-05 PlS Planned sale
0.6
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
2,753 -4.9%
0.83
US$2,285 		2,753 -4.9% 0.83 US$2,285
2024-03-04 2024-02-29 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
5,834 -3.1%
0.89
US$5,192 		5,834 -3.1% 0.89 US$5,192
2024-03-04 2024-02-29 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
3,293 -3.5%
0.89
US$2,931 		3,293 -3.5% 0.89 US$2,931
2024-03-04 2024-02-29 PlS Planned sale
0.6
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
3,293 -5.5%
0.89
US$2,931 		3,293 -5.5% 0.89 US$2,931
2024-02-12 2024-02-08 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
35,575 -16.0%
0.53
US$18,855 		35,575 -16.0% 0.53 US$18,855
2024-02-05 2024-02-01 PlS Planned sale
1.3
Posner Christopher

PRESIDENT AND CEO

Executive Director
4,981 -2.2%
0.55
US$2,740 		4,981 -2.2% 0.55 US$2,740
2023-11-03 2023-11-02 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
3,796 -2.3%
1.22
US$4,631 		3,796 -2.3% 1.22 US$4,631
2023-08-04 2023-08-03 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
4,307 -2.5%
3.07
US$13,222 		4,307 -2.5% 3.07 US$13,222
2023-06-27 2023-06-23 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,993 -1.9%
3.51
US$10,505 		2,993 -1.9% 3.51 US$10,505
2023-06-27 2023-06-23 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,723 -4.8%
3.51
US$9,558 		2,723 -4.8% 3.51 US$9,558
2023-06-27 2023-06-23 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,483 -2.7%
3.51
US$8,715 		2,483 -2.7% 3.51 US$8,715
2023-05-09 2023-05-05 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
3,869 -2.2%
4.40
US$17,024 		3,869 -2.2% 4.40 US$17,024
2023-04-06 2023-04-04 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,481 -2.7%
4.91
US$12,182 		2,481 -2.7% 4.91 US$12,182
2023-04-06 2023-04-04 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,733 -1.7%
4.91
US$13,419 		2,733 -1.7% 4.91 US$13,419
2023-04-06 2023-04-04 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,481 -4.2%
4.91
US$12,182 		2,481 -4.2% 4.91 US$12,182
2023-03-07 2023-03-03 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
6,256 -6.3%
9.71
US$60,746 		6,256 -6.3% 9.71 US$60,746
2023-03-07 2023-03-03 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
5,987 -3.3%
9.71
US$58,134 		5,987 -3.3% 9.71 US$58,134
2023-03-07 2023-03-03 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
6,802 -4.1%
9.71
US$66,047 		6,802 -4.1% 9.71 US$66,047
2023-03-07 2023-03-03 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
6,221 -9.6%
9.71
US$60,406 		6,221 -9.6% 9.71 US$60,406
2023-02-17 2023-02-16 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.4%
10.20
US$23,103 		2,265 -3.4% 10.20 US$23,103
2024-02-12 2023-02-08 PlS Planned sale
3.3
Maynard Ryan D

CHIEF FINANCIAL OFFICER

Officer
5,488 -40.7%
0.53
US$2,909 		5,488 -40.7% 0.53 US$2,909
2024-02-12 2023-02-08 PlS Planned sale
0.6
Goncalves Joana

CHIEF MEDICAL OFFICER

Officer
7,770 -11.6%
0.53
US$4,118 		7,770 -11.6% 0.53 US$4,118
2024-02-12 2023-02-08 PlS Planned sale
Terrillion Scott

SEC'Y; CHIEF COMPLIANCE & G.C.

Officer
7,770 -7.6%
0.53
US$4,118 		7,770 -7.6% 0.53 US$4,118
2023-02-03 2023-02-02 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
4,191 -2.2%
11.80
US$49,454 		4,191 -2.2% 11.80 US$49,454
2023-01-19 2023-01-17 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.3%
10.81
US$24,485 		2,265 -3.3% 10.81 US$24,485
2023-01-03 2022-12-29 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,265 -3.2%
10.18
US$23,058 		2,265 -3.2% 10.18 US$23,058
2022-12-23 2022-12-21 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
3,506 -2.1%
11.27
US$39,513 		3,506 -2.1% 11.27 US$39,513
2022-12-23 2022-12-21 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
2,561 -2.5%
11.27
US$28,862 		2,561 -2.5% 11.27 US$28,862
2022-12-23 2022-12-21 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,992 -4.0%
11.27
US$33,720 		2,992 -4.0% 11.27 US$33,720
2022-11-18 2022-11-16 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
14,470 -7.2%
11.13
US$161,051 		14,470 -7.2% 11.13 US$161,051
2022-09-16 2022-09-14 S Sale
2.0
VOGELBAUM MARTIN
Non-Executive Director
10,800 -19.4%
10.28
US$111,024 		10,800 -19.4% 10.28 US$111,024
2022-07-19 2022-07-15 PlS Planned sale
BAINS HARRISON M JR
Non-Executive Director
7,200 -22.3%
9.05
US$65,160 		7,200 -22.3% 9.05 US$65,160
2022-07-19 2022-07-15 PlS Planned sale
3.3
Ives Jeffrey L.
Non-Executive Director
3,600 -18.9%
9.05
US$32,580 		3,600 -18.9% 9.05 US$32,580
2022-04-05 2022-04-04 PlS Planned sale
1.3
Posner Christopher

President and CEO

Executive Director
2,006 -1.0%
12.67
US$25,416 		2,006 -1.0% 12.67 US$25,416
2022-04-05 2022-04-01 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
1,784 -1.0%
11.91
US$21,247 		1,784 -1.0% 11.91 US$21,247
2022-04-05 2022-04-01 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,642 -1.6%
11.91
US$19,556 		1,642 -1.6% 11.91 US$19,556
2022-04-05 2022-04-01 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,642 -2.1%
11.91
US$19,556 		1,642 -2.1% 11.91 US$19,556
2022-03-04 2022-03-03 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,787 -1.7%
11.38
US$20,336 		1,787 -1.7% 11.38 US$20,336
2022-03-04 2022-03-03 PlS Planned sale
Reilly Thomas Charles

Chief Financial Officer

Officer
2,044 -5.1%
11.38
US$23,261 		2,044 -5.1% 11.38 US$23,261
2022-03-01 2022-02-25 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,972 -1.9%
10.29
US$20,292 		1,972 -1.9% 10.29 US$20,292
2022-03-01 2022-02-25 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,114 -1.2%
10.29
US$21,753 		2,114 -1.2% 10.29 US$21,753
2022-03-01 2022-02-25 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,972 -2.5%
10.29
US$20,292 		1,972 -2.5% 10.29 US$20,292
2021-11-16 2021-11-12 S Sale
3.3
Ives Jeffrey L.
Non-Executive Director
8,180 -53.2%
16.04
US$131,207 		8,180 -53.2% 16.04 US$131,207
2021-11-03 2021-11-01 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.1%
17.15
US$17,150 		1,000 -2.1% 17.15 US$17,150
2021-10-28 2021-10-27 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.1%
15.00
US$15,000 		1,000 -2.1% 15.00 US$15,000
2021-09-01 2021-08-30 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,759 -2.4%
14.20
US$24,978 		1,759 -2.4% 14.20 US$24,978
2021-06-07 2021-06-07 PlS Planned sale
1.3
Posner Christopher
Non-Executive Director
2,304 -12.5%
13.04
US$30,044 		2,304 -12.5% 13.04 US$30,044
2021-06-07 2021-06-07 PlS Planned sale
2.0
VOGELBAUM MARTIN
Non-Executive Director
8,640 -30.0%
13.05
US$112,752 		8,640 -30.0% 13.05 US$112,752
2021-06-07 2021-06-07 PlS Planned sale
3.3
Ives Jeffrey L.
Non-Executive Director
2,520 -14.1%
13.05
US$32,886 		2,520 -14.1% 13.05 US$32,886
2021-03-24 2021-03-22 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
3,000 -8.9%
19.65
US$58,950 		3,000 -8.9% 19.65 US$58,950
2021-03-08 2021-03-05 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
3,103 -0.3%
17.98
US$55,792 		3,103 -0.3% 17.98 US$55,792
2021-03-08 2021-03-05 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
3,093 -8.4%
17.98
US$55,612 		3,093 -8.4% 17.98 US$55,612
2021-03-08 2021-03-05 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
3,358 -2.7%
17.98
US$60,377 		3,358 -2.7% 17.98 US$60,377
2021-03-08 2021-03-05 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
3,090 -5.7%
17.98
US$55,558 		3,090 -5.7% 17.98 US$55,558
2021-02-25 2021-02-25 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
5,003 -4.3%
19.33
US$96,708 		5,003 -4.3% 19.33 US$96,708
2021-02-25 2021-02-25 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
4,004 -8.3%
19.33
US$77,397 		4,004 -8.3% 19.33 US$77,397
2021-02-25 2021-02-25 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
11,729 -1.2%
19.33
US$226,722 		11,729 -1.2% 19.33 US$226,722
2021-02-25 2021-02-25 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
3,372 -11.2%
19.33
US$65,181 		3,372 -11.2% 19.33 US$65,181
2021-02-24 2021-02-22 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,000 -7.1%
19.73
US$39,460 		2,000 -7.1% 19.73 US$39,460
2021-01-25 2021-01-21 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,000 -6.7%
20.12
US$40,240 		2,000 -6.7% 20.12 US$40,240
2020-12-30 2020-12-30 PlS Planned sale
Terrillion Scott

Sec'y; Chief Compliance & G.C.

Officer
1,946 -4.4%
15.30
US$29,774 		1,946 -4.4% 15.30 US$29,774
2020-12-30 2020-12-30 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
6,078 -0.6%
15.30
US$92,993 		6,078 -0.6% 15.30 US$92,993
2020-12-30 2020-12-30 PlS Planned sale
Menzaghi Frederique Ph.D.

Chief Scientific Off,SVP-R&D

Officer
2,812 -2.5%
15.30
US$43,024 		2,812 -2.5% 15.30 US$43,024
2020-12-30 2020-12-30 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
1,298 -4.1%
15.30
US$19,859 		1,298 -4.1% 15.30 US$19,859
2020-12-29 2020-12-28 PlS Planned sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
5,000 -0.5%
16.00
US$80,000 		5,000 -0.5% 16.00 US$80,000
2020-12-23 2020-12-21 PlS Planned sale
0.6
Goncalves Joana

Chief Medical Officer

Officer
2,000 -6.8%
15.00
US$30,000 		2,000 -6.8% 15.00 US$30,000
2020-12-18 2020-12-16 S Sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
5,000 -0.5%
14.95
US$74,750 		5,000 -0.5% 14.95 US$74,750
2020-12-11 2020-12-10 S Sale
0.9
CHALMERS DEREK T

President & CEO

Executive Director
7,500 -0.8%
15.29
US$114,675 		7,500 -0.8% 15.29 US$114,675
Explore more

More insider trading research around Cara Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America